Trial Profile
A retrospective study investigated the effect of sorafenib in transarterial chemoembolization refractory patients with hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 05 Dec 2015 New trial record